美国化学品公司雅宝CEO：曾与美国政府就公私合作促进美国矿产生产的必要性进行过"一段时间"的讨 论。 ...

美国化学品公司雅宝CEO：预计到2030年，锂需求将从2024年的水平翻一番。 ...

美国化学品公司雅宝CEO：今年迄今，锂的需求已超过供应近20%。 ...

美国化学品公司雅宝CEO：估计锂市场自2022年底以来一直处于过剩状态。 ...

Q2 2025 Financial Performance - Net sales reached $1.33 billion, a decrease of 7% compared to Q2 2024's $1.43 billion[13] - Net income attributable to Albemarle Corporation increased by 112% to $23 million, compared to a loss of $188 million in Q2 2024[13] - Adjusted EBITDA was $336 million, a 13% decrease from $386 million in Q2 2024[13] - Adjusted EBITDA margin was 25%, a decrease of 200 bps from 27% in Q2 2024[13] - Adjusted diluted earnings per share attributable to common shareholders was $0.11, a 175% increase from $0.04 in Q2 2024[13] Outlook and Strategy - The company maintains its FY 2025 outlook, expecting positive free cash flow assuming current lithium market pricing persists[11, 12] - The company achieved 100% run-rate against the $400 million cost and productivity improvement target[12] - The company is reducing its full-year 2025 capital expenditure outlook to $650-700 million[12] - The company expects operating cash conversion to be >80% for FY 2025[27] Market Dynamics - Global lithium demand remains strong YTD, driven by significant growth in EVs and ESS[12, 32] - Global EV demand grew by 35% Y/Y through May[34]

Core Insights - Albemarle reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of a loss of $0.83 per share, marking an earnings surprise of +113.25% [1] - The company generated revenues of $1.33 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.98%, although this represents a decline from year-ago revenues of $1.43 billion [2] - Albemarle's stock has underperformed, losing about 16.8% since the beginning of the year compared to the S&P 500's gain of 8.3% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.60 on revenues of $1.26 billion, and for the current fiscal year, it is -$2.24 on revenues of $4.85 billion [7] - The estimate revisions trend for Albemarle was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Chemical - Diversified industry, to which Albemarle belongs, is currently in the bottom 5% of the Zacks industry rankings, suggesting a challenging environment for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Albemarle's stock performance [5]

Albemarle Corp ALB reported financial results for the second quarter after the market close on Wednesday. Here's a rundown of the report. Outlook: Albemarle affirmed its full-year 2025 revenue guidance of $4.9 billion to $5.2 billion versus estimates of $4.85 billion. The company also lowered its full-year 2025 capital expenditures outlook to a range of $650 million to $700 million. Albemarle executives will further discuss the quarter on an earnings call set for 8 a.m. Thursday morning. ALB shares are tren ...

Core Insights - Albemarle Corporation has promoted Ander Krupa to executive vice president, general counsel, corporate secretary, and chief compliance officer, effective immediately [1][2] - Krupa's leadership and legal expertise are expected to enhance Albemarle's governance framework and commitment to ethics and compliance [2] - He has over 15 years of experience in the manufacturing industry and has held various leadership roles within Albemarle since joining in May 2017 [2][4] Company Background - Albemarle Corporation is a global leader in providing essential elements for mobility, energy, connectivity, and health [1][5] - The company specializes in transforming essential resources into critical ingredients, particularly lithium and bromine, to deliver advanced solutions [5] - Albemarle emphasizes its commitment to sustainability and resilience in its operations and partnerships [5] Leadership Transition - Krupa takes over the role following the passing of the former general counsel, Stacy Grant, in April, during which he served as interim general counsel [4] - His previous roles include assistant general counsel for BWX Technologies and The Babcock & Wilcox Company, as well as experience at Greenberg Traurig LLP [3][4]

[Financial & Operational Highlights](index=1&type=section&id=Financial%20%26%20Operational%20Highlights) Albemarle reported strong Q2 results, expects positive 2025 free cash flow, and reduced capital expenditure outlook through cost management - CEO Kent Masters highlighted strong Q2 results and expects to generate positive free cash flow for the full year 2025, assuming current lithium market pricing persists, due to proactive cost and capital management[2](index=2&type=chunk) - The company achieved a **100% run-rate** against its **$400 million** cost and productivity improvement target[4](index=4&type=chunk) - Full-year 2025 capital expenditure outlook has been reduced to a range of **$650 million to $700 million**[4](index=4&type=chunk)[18](index=18&type=chunk) - Cash from operations for the first half of 2025 was **$538 million**, an increase of **$73 million** compared to the same period last year[4](index=4&type=chunk)[20](index=20&type=chunk) [Q2 2025 Financial Performance](index=1&type=section&id=Q2%202025%20Financial%20Performance) Q2 2025 saw net sales decline 7% to $1.3 billion due to lower pricing, but net income improved significantly to $23 million from a prior-year loss [Consolidated Results](index=1&type=section&id=Consolidated%20Results) Q2 2025 consolidated net sales decreased 7% to $1.33 billion, while net income significantly recovered to $22.9 million from a prior-year loss Q2 2025 Consolidated Financial Results (in millions, except per share amounts) | In millions, except per share amounts | Q2 2025 | Q2 2024 | % Change | | :--- | :--- | :--- | :--- | | **Net sales** | $1,330.0 | $1,430.4 | (7.0)% | | **Net income (loss) attributable to Albemarle** | $22.9 | $(188.2) | 112.2% | | **Adjusted EBITDA** | $336.5 | $386.4 | (12.9)% | | **Diluted loss per share** | $(0.16) | $(1.96) | 91.8% | | **Adjusted diluted EPS** | $0.11 | $0.04 | 175.0% | - The year-over-year increase in net income was primarily due to a prior-year after-tax charge of **$215 million** related to capital project asset write-offs and contract cancellation costs[5](index=5&type=chunk) [Segment Performance](index=2&type=section&id=Segment%20Performance) Energy Storage sales declined 14% due to lower pricing, while Specialties sales grew 5% and Ketjen sales slightly decreased Q2 2025 Segment Performance (in millions) | Segment | Net Sales Q2 2025 | Net Sales Q2 2024 | % Change | Adjusted EBITDA Q2 2025 | Adjusted EBITDA Q2 2024 | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **Energy Storage** | $717.7 | $830.1 | (13.5)% | $219.7 | $283.0 | (22.4)% | | **Specialties** | $351.6 | $334.6 | 5.1% | $73.0 | $54.2 | 34.7% | | **Ketjen** | $260.8 | $265.7 | (1.8)% | $28.6 | $37.8 | (24.5)% | - Energy Storage performance was impacted by lower pricing (**-28%**), which was partially offset by record production volumes (**+15%**) from its integrated conversion network[7](index=7&type=chunk) - Specialties' growth was driven by higher volumes (**+6%**) and decreased manufacturing costs from productivity initiatives[8](index=8&type=chunk) [2025 Full-Year Outlook](index=2&type=section&id=2025%20Full-Year%20Outlook) Albemarle maintains its 2025 full-year outlook, projecting sales of $4.9-$5.2 billion and adjusted EBITDA of $0.8-$1.0 billion under current lithium prices, with reduced capital expenditures [Corporate Outlook Scenarios](index=2&type=section&id=Corporate%20Outlook%20Scenarios) The 2025 full-year outlook presents net sales and adjusted EBITDA scenarios contingent on varying lithium market prices, with a base case at ~$9/kg LCE Total Corporate FY 2025 Outlook Scenarios | Observed market price case | Average lithium market price ($/kg LCE) | Net sales | Adjusted EBITDA | | :--- | :--- | :--- | :--- | | **Q2 2025 average** | ~$9 | $4.9 - $5.2 billion | $0.8 - $1.0 billion | | **H1 2024 range** | $12-15 | $5.3 - $6.1 billion | $1.2 - $1.8 billion | | **Q4 2023 average** | ~$20 | $6.5 - $7.0 billion | $2.5 - $2.7 billion | - The outlook assumes spodumene pricing averages **10%** of the lithium carbonate equivalent (LCE) price, while other costs are held constant[11](index=11&type=chunk) [Segment Outlook](index=3&type=section&id=Segment%20Outlook) FY2025 segment outlook projects Specialties net sales of $1.3-$1.5 billion and Ketjen net sales of $1.0-$1.1 billion, with Energy Storage outlook tied to lithium prices Specialties and Ketjen FY 2025 Outlook | Segment | FY 2025E Net Sales | FY 2025E Adjusted EBITDA | | :--- | :--- | :--- | | **Specialties** | $1.3 - $1.5 billion | $210 - $280 million | | **Ketjen** | $1.0 - $1.1 billion | $120 - $150 million | Energy Storage FY 2025 Outlook Scenarios | Average lithium market price ($/kg LCE) | Net sales | Adjusted EBITDA | | :--- | :--- | :--- | | **~$9** | $2.5 - $2.6 billion | $0.6 - $0.7 billion | | **$12-15** | $2.9 - $3.5 billion | $1.0 - $1.5 billion | | **~$20** | $4.2 - $4.5 billion | $2.2 - $2.4 billion | [Other Corporate Outlook](index=3&type=section&id=Other%20Corporate%20Outlook) Albemarle significantly reduced its 2025 capital expenditure forecast to $650-$700 million, a 60% decrease from 2024, with a variable adjusted effective tax rate Other Corporate FY 2025 Outlook | Metric | FY 2025E Outlook | | :--- | :--- | | **Capital expenditures** | $650 - $700 million | | **Depreciation and amortization** | $630 - $670 million | | **Adjusted effective tax rate** | (40)% - 25% | | **Corporate costs** | $40 - $70 million | | **Interest and financing expenses** | $180 - $210 million | - The 2025 capital expenditure forecast is down approximately **60%** from the **$1.7 billion** spent in 2024[18](index=18&type=chunk) [Cash Flow, Balance Sheet, and Liquidity](index=3&type=section&id=Cash%20Flow%2C%20Balance%20Sheet%2C%20and%20Liquidity) Albemarle generated $538 million in H1 2025 operating cash flow, expects positive full-year free cash flow, and maintains strong liquidity of $3.4 billion - The company now expects to achieve positive free cash flow for the full year 2025, assuming current lithium market pricing persists[20](index=20&type=chunk) - Capital expenditures for the first half of 2025 were **$302 million**, a decrease of **$732 million** from the prior-year period[20](index=20&type=chunk)[21](index=21&type=chunk) Liquidity Position as of June 30, 2025 | Metric | Amount (approx.) | | :--- | :--- | | **Total Liquidity** | $3.4 billion | | Cash and cash equivalents | $1.8 billion | | Available under revolver | $1.5 billion | | **Total Debt** | $3.6 billion | | **Net Debt to Adj. EBITDA Ratio** | 2.3x | [Appendix: Financial Statements](index=5&type=section&id=Appendix%3A%20Financial%20Statements) This appendix provides unaudited consolidated GAAP financial statements, including income, balance sheet, and cash flow data for Q2 and H1 2025 - The Consolidated Statements of Income show a net loss attributable to common shareholders of **$19.1 million** for the first six months of 2025, a significant improvement from a loss of **$239.0 million** in the first six months of 2024[27](index=27&type=chunk) - The Condensed Consolidated Balance Sheet shows total assets of **$17.3 billion** and total equity of **$10.5 billion** as of June 30, 2025[28](index=28&type=chunk) - The Selected Consolidated Cash Flow Data shows net cash provided by operating activities for the first six months of 2025 was **$538.2 million**, compared to **$465.1 million** in the prior-year period[29](index=29&type=chunk) [Consolidated Statements of Income (Loss)](index=5&type=section&id=Consolidated%20Statements%20of%20Income%20%28Loss%29) This section details revenues, costs, and net income (loss) for the three and six months ended June 30, 2025 and 2024 [Condensed Consolidated Balance Sheets](index=6&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) This section presents the company's financial position, including assets, liabilities, and equity, as of June 30, 2025 [Selected Consolidated Cash Flow Data](index=7&type=section&id=Selected%20Consolidated%20Cash%20Flow%20Data) This section details cash flows from operating, investing, and financing activities for the six months ended June 30, 2025 and 2024 [Appendix: Non-GAAP Reconciliations](index=8&type=section&id=Appendix%3A%20Non-GAAP%20Reconciliations) This appendix provides detailed reconciliations of non-GAAP financial measures, including Adjusted EBITDA and adjusted net income, to their GAAP equivalents [Reconciliation of Adjusted Net Income and Adjusted EBITDA](index=9&type=section&id=Reconciliation%20of%20Adjusted%20Net%20Income%20and%20Adjusted%20EBITDA) This table reconciles GAAP Net Income to non-GAAP Adjusted Net Income and Adjusted EBITDA, detailing adjustments for Q2 2025 Q2 2025 Reconciliation of Net Income to Adjusted EBITDA (in thousands) | Description | Amount | | :--- | :--- | | **Net income (loss) attributable to Albemarle** | $22,897 | | Add back: Interest and financing expenses | $49,939 | | Add back: Income tax expense (benefit) | $34,094 | | Add back: Depreciation and amortization | $168,731 | | **EBITDA** | **$275,661** | | Add back: Adjustments for non-recurring items, etc. | $60,814 | | **Adjusted EBITDA** | **$336,475** | [Details of Non-Recurring and Other Unusual Items](index=10&type=section&id=Details%20of%20Non-Recurring%20and%20Other%20Unusual%20Items) This section details specific non-recurring and unusual items excluded from adjusted net income, such as a $38.0 million loss from preferred equity redemption - Key non-recurring items in Q2 2025 included a **$38.0 million** loss from the redemption of preferred equity in a Grace subsidiary[42](index=42&type=chunk) - Restructuring and asset write-off charges for Q2 2025 were **$4.4 million**, primarily related to placing the Chengdu, China conversion plant into care and maintenance[36](index=36&type=chunk) [Reconciliation of Adjusted Effective Tax Rate](index=12&type=section&id=Reconciliation%20of%20Adjusted%20Effective%20Tax%20Rate) This table reconciles the GAAP effective income tax rate to the non-GAAP adjusted effective income tax rate for Q2 2025 Q2 2025 Effective Tax Rate Reconciliation | Description | Effective income tax rate | | :--- | :--- | | **As reported (GAAP)** | (380.0)% | | Non-recurring, other unusual and non-operating pension and OPEB items | N/A | | **As adjusted (Non-GAAP)** | 159.9% |

CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2025. Second-Quarter 2025 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) "We delivered strong second quarter results and are maintaining our previous outlook considerations assuming current lithium market pr ...